Grunenthal Earns PTAB Win In Challenge To Pain Treatment IP
Grunenthal GmbH has convinced the Patent Trial and Appeal Board to invalidate a patent for chronic pain treatment, notching another win Tuesday in a series of challenges it has brought against...To view the full article, register now.
Already a subscriber? Click here to view full article